Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2013
10/16/2013CN101928330B New compound and application thereof
10/16/2013CN101873866B Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
10/16/2013CN101687006B Reconstituted surfactants having improved properties
10/16/2013CN101602796B Selenium-containing active polypeptide, preparing method and application thereof
10/16/2013CN101489577B Method and compound for the treatment of valvular disease
10/15/2013US8558009 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
10/15/2013US8557978 Cross-linked glycopeptide-cephalosporin antibiotics
10/15/2013US8557962 Treatment of endothelial dysfunction in diabetic patients
10/15/2013US8557961 Alpha 1-antitrypsin compositions and methods of making and using same
10/15/2013US8557959 Allele and isotope-specific intervention on MHC class II molecules associated with autoimmune diseases by means of peptides
10/15/2013US8557958 Compositions and methods for treatment of diabetes
10/15/2013US8557957 Methods of treating disorders by administration of F11 receptor antagonists
10/15/2013US8557789 Method of treating inflammatory arthropathies with supressors of CPG oligonucleotides
10/15/2013US8557787 Diagnostic, prognostic and therapeutic uses of long non-coding RNAs for cancer and regenerative medicine
10/15/2013US8557781 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
10/15/2013US8557780 Monomethylvaline compounds capable of conjugation to ligands
10/15/2013US8557779 Cancer vaccine composition
10/15/2013US8557778 Therapeutics to inhibit MLL-menin interaction for treating leukemia
10/15/2013US8557777 Methods for treating cancer using prostate specific antigen and tumor endothelial marker peptides
10/15/2013US8557776 Compounds and methods for 18F labeled agents
10/15/2013US8557774 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
10/15/2013US8557773 Treatment of bleeding with low half-life fibrinogen
10/15/2013US8557772 Compositions having antiangiogenic activity and uses thereof
10/15/2013US8557771 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof
10/15/2013US8557770 Method of preventing or reducing scarring of human skin
10/15/2013US8557769 Co-administration of FGF-21 and GLP-1 to treat diabetes and lower blood glucose
10/15/2013US8557768 Human nerve growth factor by recombinant technology
10/15/2013US8557767 Synthetic apolipoprotein E mimicking polypeptides and methods of use
10/15/2013US8557766 3-hydroxyisothiazole 1-oxide derivatives
10/15/2013US8557765 Spatially-defined macrocycles incorporating peptide bond surrogates
10/15/2013US8557764 Methods of modulating immune function
10/15/2013US8557763 Synthetic peptides that enhance tight junction permeability
10/15/2013US8557578 Expansion medium for CD34-negative stem cells
10/15/2013US8557541 Polypeptides having glucoamylase activity and polynucleotides encoding same
10/15/2013US8557288 Hydrogel microparticle formation in aqueous solvent for biomedical applications
10/15/2013US8557281 Water-swellable polymers
10/15/2013US8557256 Treatment for cervical dystonia with the neurotoxic component of a botulinum toxin
10/15/2013US8557247 Lyophilised antigen composition
10/15/2013US8557243 EFGR antibodies comprising modular recognition domains
10/15/2013US8557242 ERBB2 antibodies comprising modular recognition domains
10/15/2013US8557238 EG-VEGF nucleic acids and polypeptides and methods of use
10/15/2013US8557237 Crème comprising encapsulated bromelain for the skin, specifically for inhibiting ingrown hair
10/15/2013US8557236 Cardiovascular support supplement and compositions and methods thereof
10/15/2013US8557232 Stabilization of Fc-interferon-beta fusion proteins
10/15/2013US8557231 Biodegradable poly(beta-amino esters) and uses thereof
10/15/2013CA2604327C Pharmaceutical aerosol composition
10/15/2013CA2589951C Method for producing carboxy-terminal amidated peptides
10/15/2013CA2516322C Glycosaminoglycan-dnase combination therapy
10/15/2013CA2515607C Use of lupinus albus conglutin gamma for the treatment of type ii diabetes
10/15/2013CA2494844C Methods and compositions concerning poxviruses and cancer
10/15/2013CA2483602C Fgf variants and methods for use thereof
10/15/2013CA2452119C Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof
10/15/2013CA2410762C Feline hepatocyte growth factor
10/15/2013CA2373721C Compounds that bind her2
10/15/2013CA2367856C Analogs of gastric inhibitory peptide and their use for treatment of diabetes
10/10/2013WO2013152291A1 Cell therapy technology to deliver radio-protective peptides
10/10/2013WO2013152272A1 ΑΖΑ-β-LACTAM COMPOUNDS AND METHODS OF USING
10/10/2013WO2013152252A1 Combination anti-cancer therapy
10/10/2013WO2013152213A1 Methods and compositions for increasing red blood cells
10/10/2013WO2013152169A1 Polypeptides and their use in treating metapneumovirus (mpv) infection
10/10/2013WO2013152076A1 Compositions and methods for treating hypertension
10/10/2013WO2013152041A1 Targeting senescent and cancer cells for selective killing by interference with foxo4
10/10/2013WO2013151999A1 Cancer treatment and immune system regulation through fat10 pathway inhibition
10/10/2013WO2013151910A1 Methods and compositions for reducing the incidence of post-surgical adhesions
10/10/2013WO2013151774A1 Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane
10/10/2013WO2013151767A1 Therapy for kidney disease and/or heart failure by intradermal infusion
10/10/2013WO2013151766A1 Therapy for kidney disease and/or heart failure by intradermal infusion
10/10/2013WO2013151744A1 Materials and methods for treatment of cystic fibrosis and for induction of ion secretion
10/10/2013WO2013151729A1 Compositions, methods and assays comprising amylin or amlyin analogs for abeta-peptide mediated disorders
10/10/2013WO2013151688A1 Methods and compositions for using insulin-like growth factor binding protein 6 in treating and diagnosing diabetes
10/10/2013WO2013151677A1 Ddr2 mutations in cancer
10/10/2013WO2013151595A1 Improved adjuvant system for oral vaccine adminstration
10/10/2013WO2013151568A1 Methods of treatment with arginine deiminase
10/10/2013WO2013151314A1 Composition comprising vimentin for inhibiting hair loss or promoting hair growth
10/10/2013WO2013150518A1 Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
10/10/2013WO2013150338A1 Stapled cell penetrating peptides for intracellular delivery of molecules
10/10/2013WO2013150295A1 Food supplement to support brain function
10/10/2013WO2013150138A1 Secretory immunoglobulin complex
10/10/2013WO2013149809A1 Mixture of enzymes from antarctic krill for use in the removal of a biofilm
10/10/2013WO2013149506A1 Chimeric peptide based on opioid peptide biphalin and neuropeptide ff and synthesis and use thereof
10/10/2013WO2013149355A1 Use of angiotensin 1-9 in combination in order to prevent arterial hypertension
10/10/2013WO2013103424A9 Silk-based multifunctional biomedical platform
10/10/2013WO2013102921A3 Hcg - newer treatment modality for type 2 diabetes mellitus (t2dm)
10/10/2013WO2013090454A3 Carboxylic acid derivatives comprising four cycles acting as glp-1 receptor modulators for therapy of diseases such as diabetes
10/10/2013WO2013087727A8 New efficient interferon-based treating methods
10/10/2013WO2013084000A3 Exosomes for delivery of biotherapeutics
10/10/2013WO2012040295A3 Therapeutic applications of smad7
10/10/2013WO2011115712A8 Tfpi inhibitors and methods of use
10/10/2013US20130267713 Hepatitis C Virus Inhibitors
10/10/2013US20130267473 Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
10/10/2013US20130267471 Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
10/10/2013US20130267470 Treatment Of Penetrative Injury To The Brain
10/10/2013US20130267469 Ipa as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
10/10/2013US20130267468 Factor viii glycoforms
10/10/2013US20130267463 Pharmaceutical composition for preventing or treating th17-mediated disease comprising poly-gamma-glutamic acid
10/10/2013US20130267462 Lipid Construct for Delivery of Insulin to a Mammal
10/10/2013US20130267461 Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (dcir) activity and signaling events
10/10/2013US20130267460 Methods of Inhibiting Alphavirus Replication and Treating Alphavirus Infection
10/10/2013US20130267459 Anti-Pathogen Systems
10/10/2013US20130267458 Compositions and uses of materials with high antimicrobial activity and low toxicity
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 3163